SURVEY ON THE STATUS OF HEART FAILURE TREATMENT ACCORDING TO THE MINISTRY OF HEALTH GUIDELINES (2022) AT TRUNG VUONG HOSPITAL
Main Article Content
Abstract
Objective: To evaluate the adherence to heart failure treatment guidelines issued by the Ministry of Health at Trung Vuong Hospital.
Methods: A cross-sectional descriptive study was conducted on 119 heart failure patients. Logistic and linear regression analyses were utilized to identify factors influencing reduced ejection fraction and the total number of medication classes prescribed.
Results: The proportion of patients receiving foundational medication classes was very high: renin-angiotensin system inhibitors (92.4%), sodium-glucose cotransporter-2 inhibitors (90.8%), mineralocorticoid receptor antagonists (84.8%), and beta-blockers (82.4%). Notably, 61.3% of patients achieved the standard quadruple therapy. Sodium-glucose cotransporter-2 inhibitors reached an optimal target dose rate of 89.9%. In contrast, renin-angiotensin system inhibitors, beta-blockers, and mineralocorticoid receptor antagonists had target dose achievement rates of less than 1%. Chronic kidney disease was the only statistically significant barrier that reduced the number of combined medication classes (regression coefficient B = -0.670; p < 0.001).
Conclusion: Trưng Vương Hospital has successfully implemented early multidrug therapy for heart failure patients, particularly with the prominent use of sodium-glucose cotransporter-2 inhibitors. However, the target dose achievement rate for conventional medications remains low, necessitating individualized dose titration strategies.
Article Details
Keywords
Heart failure, ejection fraction, renin-angiotensin system inhibitors, beta-blockers, mineralocorticoid receptor antagonists.
References
[2] Đỗ Doãn Lợi. Suy tim trong kỷ nguyên y học cá thể hóa và chuyển đổi số. Tài liệu Hội nghị Khoa học toàn quốc Phân hội Suy tim (Hội Tim mạch Việt Nam) lần thứ II, thành phố Hồ Chí Minh, 13/12/2025.
[3] Lê Minh Trí. Điều trị suy tim phân suất tống máu giảm theo khuyến cáo hội Tim Mạch Việt Nam tại Bệnh viện Tâm Đức. Luận văn bác sĩ chuyên khoa II, Trường Đại học Y khoa Phạm Ngọc Thạch, 2023.
[4] Nguyễn Ngọc Thanh Vân và cộng sự. Khảo sát điều trị suy tim theo khuyến cáo của Hội Tim mạch châu Âu. Tạp chí Y học thành phố Hồ Chí Minh 2016, 2021, 25 (2): 35-41. doi: 10.34810/vjs2021206.
[5] Greene S.J et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. Journal of the American College of Cardiology, 2018, 72 (4): 351-366. doi: 10.1016/j.jacc.2018.04.070.
[6] Patil T et al. Impact of pharmacist-led heart failure clinic on optimization of guideline-directed medical therapy (PHARM-HF). Journal of Cardiovascular Translational Research, 2022, 15 (6): 1424-1435. doi: 10.1007/s12265-022-10262-9.
[7] Linssen G.C et al. Regional variations in heart failure care: evidence from the CHECK-HF registry. JACC: heart failure, 2022, 10 (4), 278-287. doi: 10.1016/j.jchf.2022.01.003.
[8] MacDonald M.R, Tay W.T et al. Regional variation of mortality in heart failure with reduced and preserved ejection fraction across ASIA: outcomes in the ASIAN‐HF registry. Journal of the American Heart Association, 2020, 9 (1): e012199. doi: 10.1161/JAHA.119.012199.
[9] Mai Xuân Tiến và cộng sự. Sử dụng thuốc ức chế SGLT2 ở bệnh nhân suy tim mạn phân suất tống máu giảm theo khuyến cáo của Hội Tim mạch học Việt Nam. Tạp chí Y học Việt Nam, 2025, 546 (3): 325-329. doi: 10.51298/vmj.v546i3.12767.